31 related articles for article (PubMed ID: 15476281)
1. Anticancer Effects of
Han EJ; Choi EY; Jeon SJ; Moon JM; Lee SW; Lee JH; Jung GH; Han SH; Jung SH; Yang MS; Jung JY
J Med Food; 2024 Apr; 27(4):330-338. PubMed ID: 38387002
[TBL] [Abstract][Full Text] [Related]
2. Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy.
Kim R; Kin T; Beck WT
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473345
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer.
Guo Y; Wang M; Zou Y; Jin L; Zhao Z; Liu Q; Wang S; Li J
J Nanobiotechnology; 2022 Aug; 20(1):371. PubMed ID: 35953863
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D Analogs Potentiate the Antitumor Effect of Imatinib Mesylate in a Human A549 Lung Tumor Model.
Maj E; Filip-Psurska B; Świtalska M; Kutner A; Wietrzyk J
Int J Mol Sci; 2015 Nov; 16(11):27191-207. PubMed ID: 26580599
[TBL] [Abstract][Full Text] [Related]
5. Transfection of PDCD5 effect on the biological behavior of tumor cells and sensitized gastric cancer cells to cisplatin-induced apoptosis.
Xu HY; Chen ZW; Pan YM; Fan L; Guan J; Lu YY
Dig Dis Sci; 2012 Jul; 57(7):1847-56. PubMed ID: 22359193
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of oblimersen sodium in combination with cisplatin and 5-fluorouracil in patients with advanced esophageal, gastroesophageal junction, and gastric carcinoma.
Raab R; Sparano JA; Ocean AJ; Christos P; Ramirez M; Vinciguerra V; Kaubisch A
Am J Clin Oncol; 2010 Feb; 33(1):61-5. PubMed ID: 19738454
[TBL] [Abstract][Full Text] [Related]
7. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library.
Zhao L; Pan Y; Gang Y; Wang H; Jin H; Tie J; Xia L; Zhang Y; He L; Yao L; Qiao T; Li T; Liu Z; Fan D
J Biol Chem; 2009 Sep; 284(39):26273-85. PubMed ID: 19638344
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for Bcl-2 homology 3 domain recognition in the Bcl-2 protein family: identification of conserved hot spot interactions.
Moroy G; Martin E; Dejaegere A; Stote RH
J Biol Chem; 2009 Jun; 284(26):17499-511. PubMed ID: 19293158
[TBL] [Abstract][Full Text] [Related]
9. The mitochondrial death pathway: a promising therapeutic target in diseases.
Gupta S; Kass GE; Szegezdi E; Joseph B
J Cell Mol Med; 2009 Jun; 13(6):1004-33. PubMed ID: 19220575
[TBL] [Abstract][Full Text] [Related]
10. Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide.
Wiedenmann N; Koto M; Raju U; Milas L; Mason KA
Invest New Drugs; 2007 Oct; 25(5):411-6. PubMed ID: 17492397
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for gastric cancer: is it promising?
Sutter AP; Fechner H
World J Gastroenterol; 2006 Jan; 12(3):380-7. PubMed ID: 16489636
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapy against Bcl-2-related proteins in breast cancer cells.
Emi M; Kim R; Tanabe K; Uchida Y; Toge T
Breast Cancer Res; 2005; 7(6):R940-52. PubMed ID: 16280040
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of p53 and bcl-2 immunoreactivity for early invasive pT1/pT2 gastric carcinomas: indicators for limited gastric resections?
Kopp R; Diebold J; Dreier I; Cramer C; Glas J; Baretton G; Jauch KW
Surg Endosc; 2005 Nov; 19(11):1507-12. PubMed ID: 16177872
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of antisense bcl-2 as a chemosensitizer for patients with gastric carcinoma.
Kim R; Emi M; Tanabe K; Toge T
Cancer; 2004 Nov; 101(10):2177-86. PubMed ID: 15476281
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model.
Wacheck V; Heere-Ress E; Halaschek-Wiener J; Lucas T; Meyer H; Eichler HG; Jansen B
J Mol Med (Berl); 2001 Oct; 79(10):587-93. PubMed ID: 11692156
[TBL] [Abstract][Full Text] [Related]
16. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic potential of antisense (AS) Bcl-2 as a chemosensitizer for patients with gastric and breast carcinoma].
Kim R; Emi M; Matsuura K; Tanabe K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1540-5. PubMed ID: 16315863
[TBL] [Abstract][Full Text] [Related]
18. Lessons from anticancer research might provide new insights into mechanisms of hormone action.
Buckley AR
Trends Endocrinol Metab; 2001 Apr; 12(3):87-9. PubMed ID: 11306332
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and therapy of malignant diseases of the hematopoietic system.
Gruber J; Greil R
Int Arch Allergy Immunol; 1994 Dec; 105(4):368-73. PubMed ID: 7981607
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
